
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
Following concern at how wealthy individuals, many with Russian connections, had used the threat of litigation to stifle criticism and investigative journalism, ECCTA introduces measures to prevent SLAPPS: Strategic Litigation Against Public Participation. It provides the first statutory definition of SLAPPS and requires changes to the Civil Procedure Rules to enable courts to hear applications to dismiss such claims.
For a claim to be a SLAPP under ECCTA, it must have the effect or intended effect of restraining the defendant’s freedom of speech in the context of information relating to a reasonable suspicion of economic crime. The litigation must also be conducted in a way intended to cause the defendant harassment, alarm, distress, expense or other harm “beyond that encountered in the course of properly conducted litigation”.
The definition of a SLAPP is narrower than some had sought, being limited to where accusations of economic crime are present. Attempts to silence those seeking to highlight human rights abuses, environmental damage and other issues of public interest will not be caught by this change. However, a private member’s bill seeking to widen this definition to any matter of public interest is currently at the committee stage in Parliament. This revised definition is still thought by some to be ineffective due to the subjective nature of the definition.
Amendments to the CPR are currently awaited, but it is expected that they will comply with the legislation by making additions to the existing rules on the striking out of claims. Judges will then face some difficult decisions on whether certain defamation claims are legitimate, or demonstrate an intention to use litigation tactically to thwart public debate.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the SLAPPs team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

02 July 2026 Event
Join our upcoming event that will feature speakers from J.P. Morgan, Bank of America, and Simmons & Simmons

11 June 2026 Event
Join our webinar to be up-to-date with the regulatory developments in the asset management sector
_11zon.jpg?width=380&width=380&format=webply&auto=webp)
09 June 2026 Publication
The FCA has publishes a new webpage, setting out an update on proposed reforms to the UK MMF Regulation

09 June 2026 Publication
A summary of the Central Bank of Ireland's Markets Update No 8 of 2026 for regulated firms and other market participants